Riskpilot← Back to searchSign inGet full accessKonsultax AB
ABBankruptOrg 5590045570Medical specialists activities · NACE 8622Est. 20153 employees
Revenue 2019
SEK 1,9M
+16% vs 2018
EBITDA margin
3.4%
-70% vs 2018
Equity ratio
41.8%
Financial strength
Net profit 2019
SEK 39K
-75% vs 2018
| Revenue | SEK 1,9M | +16% |
| EBITDA | SEK 65K | -70% |
| Net profit | SEK 39K | -75% |
| Total assets | SEK 237K | -39% |
| Equity | SEK 99K | -62% |
| Employees | 3 | — |
Legal name
Konsultax AB
Org number
5590045570
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 februari 2015
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-03-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolagets ska bedriva läkarkonsultverksamhet, kursverksamhet och föreläsningar inom hälso- och sjukvården, personaluthyrning och konsultverksamhet inom IT och sjukvård, utveckla och bedriva webbsidor samt idka handel med värdepapper, äga och förvalta fastigheter samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | 2 165 | 1 673 | 1 619 | 1 886 |
| Staff expenses | — | — | — | — |
| EBITDA | 278 | −18 | 217 | 65 |
| Depreciation & amort. | −9 | −9 | −5 | −4 |
| EBIT | 269 | −27 | 212 | 61 |
| Net financials | −2 | −1 | −5 | −1 |
| Profit before tax | 267 | −28 | 207 | 60 |
| Tax | −60 | −0 | −49 | −21 |
| Net profit | 207 | −28 | 158 | 39 |
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Total assets | 392 | 350 | 386 | 237 |
| Equity | 257 | 229 | 262 | 99 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 135 | 121 | 123 | 138 |
| Total debt | 135 | 121 | 123 | 138 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20162019
Equity ratio
41.8%
This company
38.2%
Market median
+9% vs market
20162019
Return on equity
39.4%
This company
18.4%
Market median
+114% vs market
20162019
Net profit margin
2.1%
This company
8.1%
Market median
-74% vs market
20162019
Asset turnover
7.96×
This company
1.12×
Market median
+611% vs market
20162019
Debt / equity
1.39×
This company
0.62×
Market median
-124% vs market
20162019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-04-01 – 2018-03-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-04-01 – 2017-03-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-02-01 – 2016-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RD Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Konsultax AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rikard Dag Lemming | Liquidator | 0 companies |
| Shilan Salem Ali | Deputy Board Member | 0 companies |
| Ghazwan Rasheed Anjo | Board of Directors | 0 companies |